Skip to main content
NAC Logo NAC Logo (English) NAC Logo (Français)
National Advisory Committee on Blood and Blood Products (NAC)
  • EN
  • FR
  • Blood Shortage
  • Endorsements
  • Guidelines & Recommendations
    • COVID-19 Pandemic Resources
    • Blood Component Transfusion Recommendations
    • Plasma Protein and Related Products Recommendations
    • Special Testing / Modification Recommendations
    • Adverse Event Recommendations
  • Links & Resources
NAC Logo NAC Logo (English) NAC Logo (Français)
National Advisory Committee on Blood and Blood Products (NAC)

Main navigation

  • Blood Shortage
  • Endorsements
  • Guidelines & Recommendations
    • COVID-19 Pandemic Resources
    • Blood Component Transfusion Recommendations
    • Plasma Protein and Related Products Recommendations
    • Special Testing / Modification Recommendations
    • Adverse Event Recommendations
  • Links & Resources
  • EN
  • FR
Photo of medical worker's gloved hand holding a blood bag

You are here

  • Home
  • Blood Shortage

Blood Shortage

Blood and blood products are a vital part of patient health care across Canada. The National Advisory Committee on Blood and Blood Products has developed frameworks for managing supplies of blood components and plasma protein and related products (PPRPs) in times of shortage.

Labile Blood Components

  • Document
    The National Plan for Management of Shortage of Labile Blood
Red Phase Emergency Framework
  • Document
    Emergency framework for rationing of blood for massively bleeding patients during a red phase blood shortage
  • Document
    Synopsis for Triage Team
  • Document
    Blood Shortage and Massive Transfusion Working Group
  • Document
    Identification and Selection of Studies
  • Document
    References (ethical frameworks and allocation protocols)

Immunoglobulin Product

  • Document
    Project Underway to develop a National Plan for Management of Shortages of Immunoglobulin Products
  • Document
    The National Plan for Management of Shortages of Immunoglobulin Products (Ig) Interim Guidance
Intravenous Immunoglobulin (IVIg) Brand Switching Guidance and Resources
  • Document
    NAC IVIg Brand Switching Guidance
  • Document
    Fact Sheet- Cdn Ig SupplyIVIg Brand Switching
  • Document
    TSO1337 Switching IVIG Brands - Alberta Public Labs
  • Document
    Template Communication IVIg Brand Switch - Doctor (Word doc)
  • Document
    Template Communication IVIg Brand Switch - Patient (Word doc)

Provincial Shortage Simulation Reports

 

2018 

 

Ontario

2016
Document
NB Simulation Exercise
2014
Document
New Brunswick

Ontario 

2011
Document
British Columbia
Document
New Brunswick

Nova Scotia

2010

Newfoundland and Labrador

Ontario

NAC Logo NAC Logo (English) NAC Logo (Français)
National Advisory Committee on Blood and Blood Products (NAC)

NAC

  • Blood Shortage
  • Endorsements
  • Guidelines & Recommendations
  • Links & Resources

Recently updated resources

  • NAC Recommendations for Solvent Detergent Plasma (S/D Plasma)
  • Recommendations for Use of Prothrombin Complex Concentrates in Canada
  • NAC Statement on the Introduction of Leukocyte Reduced Whole Blood in Canada
  • NAC Patient Blood Management Statement
  • Massive Transfusion Consensus Conference

Contact

NAC Chair

Alan Tinmouth

NAC Project Coordinator

Harleen Kahlon

ONBlood@ontario.ca

© Copyright 2023. National Advisory Committee on Blood and Blood Products. All rights reserved. Disclaimer & Privacy Info